生存者照护计划对卵巢癌患者2年随访期间患者报告结局的影响——ROGY照护试验
该实用整群随机试验将荷兰南部12家医院随机分为「生存者照护计划(SCP)照护」组或「常规照护」组,评估自动生成的SCP对卵巢癌患者报告结局的长期影响。共174例卵巢癌患者完成问卷,结果显示两组在信息提供满意度、照护满意度或医疗利用方面无总体差异;SCP组患者认为治疗有助于治愈疾病的信念更低(总体6.7 vs 7.5,P<0.01)。结论提示SCP未提高满意度,卵巢癌患者可能无法从SCP中获益。
要点
- SCP组与常规照护组在信息提供满意度、照护满意度及医疗利用方面无总体差异。
- SCP组患者认为治疗有助于治愈疾病的信念低于常规照护组(总体6.7 vs 7.5,P<0.01)。
- 试验结果提示卵巢癌患者可能无法从SCP中获益。
核心结论
- SCP未提高卵巢癌患者对信息提供或照护的满意度。
- 试验结果提示卵巢癌患者可能无法从SCP中获益。
研究设计与样本
- 实用整群随机试验,荷兰南部12家医院随机分为「SCP照护」组或「常规照护」组。
- 卵巢癌患者N=174,平均年龄63.3岁(SD=11.4),涵盖所有分期。
- 患者在初始治疗后及6、12、24个月完成问卷。
主要发现
- SCP照护组首次问卷返回61例(67%),常规照护组113例(72%)。
- SCP照护组中66%(N=41)的患者报告收到SCP。
- 两组在信息提供满意度、照护满意度或医疗利用方面无总体差异。
- 关于疾病感知,SCP照护组患者认为治疗有助于治愈疾病的信念更低(总体6.7 vs 7.5,P<0.01)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to assess the long-term impact of an automatically generated Survivorship Care Plan (SCP) on patient reported outcomes in ovarian cancer in routine clinical practice. Outcome measures included satisfaction with information provision and care, illness perceptions and health care utilization. METHODS: In this pragmatic cluster randomized trial, twelve hospitals in the South of the Netherlands were randomized to 'SCP care' or 'usual care'. All newly diagnosed ovarian cancer patients in the 'SCP care' arm received an SCP that was automatically generated by the oncology provider, by clicking a button in the web-based Registrationsystem Oncological GYnecology (ROGY). Ovarian cancer patients (N=174, mean age 63.3, SD=11.4; all stages) completed questionnaires directly after initial treatment and after 6, 12 and 24months. RESULTS: First questionnaires were returned from 61 (67%) ovarian cancer patients in the 'SCP care' arm and 113 (72%) patients in the 'usual care' arm. In the 'SCP care' arm, 66% (N=41) of the patients reported receipt of an SCP. No overall differences were observed between the trial arms on satisfaction with information provision, satisfaction with care or health care utilization. Regarding illness perceptions, patients in the 'SCP care' arm had lower beliefs that the treatment would help to cure their disease (overall, 6.7 vs. 7.5, P<0.01). CONCLUSIONS: SCPs did not increase satisfaction with information provision or care in ovarian cancer patients. Our trial results suggest that ovarian cancer patients may not benefit from an SCP. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01185626.
引用
- de Rooij BH, Ezendam NPM, Nicolaije KAH, et al. Effects of Survivorship Care Plans on patient reported outcomes in ovarian cancer during 2-year follow-up - The ROGY care trial. Gynecol Oncol. 2017. PMID: 28283195. doi:10.1016/j.ygyno.2017.02.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。